» Articles » PMID: 34124009

Nanogold Functionalized With Lipoamide-DGR: A Simple, Robust and Versatile Nanosystem for αvβ3-Integrin Targeting

Overview
Journal Front Chem
Specialty Chemistry
Date 2021 Jun 14
PMID 34124009
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

Gold nanoparticles functionalized with DGR, a tripeptide motif that recognizes αvβ3 integrin overexpressed in tumor vessels, have been used as nano-vectors for the delivery of cytokines to tumors. Functionalization of nanogold with this peptide has been achieved by coating nanoparticles with a peptide-albumin conjugate consisting of heterogeneous molecules with a variable number of linkers and peptides. To reduce nanodrug heterogeneity we have designed, produced and preclinically evaluated a homogeneous and well-defined reagent for nanogold functionalization, consisting of a head-to-tail cyclized CGDGRG peptide () coupled its thiol group to maleimide-PEG-lipoamide (LPA). The resulting -PEG-LPA compound can react with nanogold lipoamide to form a stable bond. studies have shown that , after coupling to nanogold, maintains its capability to bind purified αvβ3 and αvβ3-expressing cells. Nanogold functionalized with this peptide can also be loaded with bioactive tumor necrosis factor-α (TNF) to form a bi-functional nanodrug that can be stored for three days at 37°C or >1 year at low temperatures with no loss αvβ3-binding properties and TNF-cytolytic activity. Nanoparticles functionalized with both and TNF induced tumor eradication in WEHI-164 fibrosarcoma-bearing mice more efficiently than nanoparticles lacking the targeting moiety. These results suggest that -PEG-LPA is an efficient and well-defined reagent that can be used to produce robust and more homogeneous nano-vectors for the delivery of TNF and other cytokines to αvβ3 positive cells.

Citing Articles

Delivery of Theranostic Nanoparticles to Various Cancers by Means of Integrin-Binding Peptides.

Egorova E, Nikitin M Int J Mol Sci. 2022; 23(22).

PMID: 36430214 PMC: 9696485. DOI: 10.3390/ijms232213735.

References
1.
Frederix F, Friedt J, Choi K, Laureyn W, Campitelli A, Mondelaers D . Biosensing based on light absorption of nanoscaled gold and silver particles. Anal Chem. 2003; 75(24):6894-900. DOI: 10.1021/ac0346609. View

2.
Shenoi M, Iltis I, Choi J, Koonce N, Metzger G, Griffin R . Nanoparticle delivered vascular disrupting agents (VDAs): use of TNF-alpha conjugated gold nanoparticles for multimodal cancer therapy. Mol Pharm. 2013; 10(5):1683-94. PMC: 3744664. DOI: 10.1021/mp300505w. View

3.
Libutti S, Paciotti G, Byrnes A, Alexander Jr H, Gannon W, Walker M . Phase I and pharmacokinetic studies of CYT-6091, a novel PEGylated colloidal gold-rhTNF nanomedicine. Clin Cancer Res. 2010; 16(24):6139-49. PMC: 3004980. DOI: 10.1158/1078-0432.CCR-10-0978. View

4.
Paladino A, Civera M, Curnis F, Paolillo M, Gennari C, Piarulli U . The Importance of Detail: How Differences in Ligand Structures Determine Distinct Functional Responses in Integrin α β. Chemistry. 2019; 25(23):5959-5970. DOI: 10.1002/chem.201900169. View

5.
Paciotti G, Zhao J, Cao S, Brodie P, Tamarkin L, Huhta M . Synthesis and Evaluation of Paclitaxel-Loaded Gold Nanoparticles for Tumor-Targeted Drug Delivery. Bioconjug Chem. 2016; 27(11):2646-2657. PMC: 5356508. DOI: 10.1021/acs.bioconjchem.6b00405. View